Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TWINCORE is a leading German infection research institute bridging basic science and clinical application. It has developed innovative platforms like MEMUMAB for rapid identification of therapeutic antibodies against infectious agents. Recent advances include adapting hepatitis C virus to mouse models, discovering new drug candidates against RSV, elucidating immune evasion by cytomegalovirus, and identifying new starting points against bacterial pathogens such as Pseudomonas aeruginosa. The institute’s work spans from molecular mechanism discovery to the development of potential therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TWINCORE.